Blog, Organ Transplantation

Understanding Immutil-S 360 Tablet DR in Organ Transplantation

Immutil S 360 Tablet Uses

Immutil S 360 Tablet DR is a vital immunosuppressant medication manufactured by La Renon Healthcare Pvt Ltd. This medication contains Mycophenolate sodium (360mg), belonging to a class of drugs called immunosuppressants. It is primarily prescribed to prevent organ rejection posttrans plantation, such as kidney, heart, or liver transplants.

By weakening the body’s immune system, Immutil S 360 Tablet DR reduces the likelihood of the immune system attacking the newly transplanted organ. It is crucial to follow the prescribed dosage regimen meticulously, as instructed by a healthcare professional. The tablets can be taken with or without food but should be swallowed whole, without crushing or breaking them.

While Immutil S 360 Tablet DR is generally well tolerated, it may cause side effects such as nausea, vomiting, diarrhea, abdominal pain, headache, and high blood pressure. Due to its immune suppressing properties, individuals may be more prone to infections and have an increased risk of certain cancers. Pregnant or breastfeeding individuals, as well as those with ongoing infections or a history of digestive system disorders, should avoid this medication.

Immutil S 360 Tablet
Send Enquiry

Immutil S 360 Tablet DR plays a crucial role in ensuring the success of organ transplantation by helping the body accept the new organ. However, careful monitoring and adherence to medical advice are essential to mitigate potential risks and optimize treatment outcomes.

Benefits of Immutil S 360 Tablet

Immutil S 360 Tablet DR offers invaluable benefits in preventing organ rejection posttransplantation. By suppressing the body’s immune response, it significantly reduces the risk of the transplanted organ being attacked. This medication, when used in conjunction with other therapies, enhances the body’s acceptance of the new organ, thereby increasing the likelihood of transplant success. Immutil S 360 Tablet DR plays a pivotal role in improving the quality of life for transplant recipients, allowing them to enjoy prolonged health and wellbeing. Its efficacy lies in its ability to safeguard transplanted organs, providing patients with renewed hope and vitality for the future.

Side Effects of Immutil S 360 Tablet

While Immutil S 360 Tablet DR is crucial for preventing organ rejection posttransplantation, it may entail certain side effects that individuals should be aware of. Common adverse reactions include gastrointestinal discomfort such as nausea, vomiting, and diarrhea, as well as abdominal pain and headaches. Additionally, the medication can elevate blood pressure levels and lead to changes in the number of white blood cells, potentially increasing the susceptibility to infections. Individuals may also experience anxiety, breathlessness, and muscle pain as a result of Immutil S 360 Tablet DR usage.

Common Side Effects

  • Nausea
  •  Vomiting
  •  Diarrhea
  •  Abdominal pain
  •  Headache
  •  High blood pressure
  •  Decreased white blood cell count (neutrophils)
  •  Increased susceptibility to bacterial and fungal infections
  •  Pneumonia
  •  Increased uric acid levels in the blood
  •  Electrolyte imbalance
  •  Anxiety
  •  Breathlessness
  •  Elevated creatinine levels in the blood
  •  Anemia
  •  Acne
  •  Muscle pain

In conclusion, while Immutil-S 360 Tablet DR is an essential medication for preventing organ rejection post-transplantation, it’s imperative to acknowledge and manage potential side effects. With careful monitoring and adherence to medical advice, individuals can mitigate risks and optimize treatment outcomes. Despite the possibility of adverse reactions, the benefits of Immutil-S 360 Tablet DR in safeguarding transplanted organs and improving quality of life for recipients are profound. By working closely with healthcare providers and remaining vigilant for any concerning symptoms, patients can navigate the transplant journey with confidence, embracing renewed hope and vitality for the future.

Leave a Reply

Your email address will not be published. Required fields are marked *